Target intelligence / Profile preview

Salmonella surface antigen

Molecular classification
Bacterial surface antigen, Lipopolysaccharide, Flagellin, Capsular polysaccharide, Glycoprotein
01

Overview

Salmonella surface antigens are a complex array of molecules on the bacterial cell wall that determine the serological identity and virulence of Salmonella species (Source: CDC, 2022). These antigens are traditionally classified into three types: the somatic O-antigen (part of the lipopolysaccharide layer), the flagellar H-antigen (composed of flagellin proteins), and the capsular Vi-antigen found primarily in Salmonella Typhi (Source: StatPearls, 2023). The O-antigen is crucial for structural integrity and protecting the bacterium from the host's complement-mediated killing, while the H-antigen facilitates motility and invasion of host cells (Source: UniProt, 2024). The Vi-antigen acts as a protective shield, preventing antibody binding and phagocytosis, thereby enhancing the systemic spread of the pathogen (Source: PubMed, PMID: 28533306). These surface components are the primary targets for both diagnostic serotyping via the Kauffmann-White scheme and for preventive vaccines (Source: WHO, 2023). Current vaccines, such as the Vi capsular polysaccharide and the live-attenuated Ty21a strain, work by inducing protective immune responses against these specific surface structures to prevent diseases like typhoid fever and salmonellosis.

Other names
Somatic O antigenFlagellar H antigenCapsular Vi antigenSalmonella lipopolysaccharideKauffmann-White antigensBacterial surface antigens (Salmonella)
02

Mechanism of action

Active immunization through the induction of humoral and cellular immune responses against bacterial surface components to prevent host cell attachment and invasion; or direct binding and neutralization of lipopolysaccharide components to mitigate endotoxicity.

03

Biological functions

Bacterial adhesionBacterial motilityImmune evasionPathogenesisEndotoxin activityStructural integrity
04

Disease associations

Typhoid feverParatyphoid feverSalmonellosisGastroenteritisSepticemia
05

Safety considerations

Endotoxic shock associated with lipopolysaccharide releaseInjection site reactionsTransient fever and systemic inflammatory responsesPotential for cross-reactivity with host tissuesLimited protection against non-vaccine serotypes
06

Interacting drugs

Typhoid vaccine (Vi capsular polysaccharide)

4 more in the full profile.

07

Biomarkers

O-antigen serotypingH-antigen serotypingVi-antigen detectionWidal test titersAnti-LPS antibodiesAnti-Vi IgG titers

Beyond the preview

Go deeper on Salmonella surface antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella surface antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call